A groundbreaking study will investigate Parkinson’s disease in unprecedented detail, with the aim of discovering a cure for the condition.

Landmark is a groundbreaking three-year research programme that aims to understand Parkinson’s in unprecedented detail. The ...

Pharmac | Te Pātaka Whaioranga is widening access to a medicine to treat urinary tract infections and funding a combination medicine for people with Parkinson's disease. “Over 3,100 New Zealanders ...

Patients with Parkinson’s disease (PD) suffer from a variety of movement disorders caused by a breakdown of brain neurons.

Parkinson’s is the fastest growing neurological condition in the world and affects around 153,000 people in the UK.

Parkinson's comes on slowly, and diagnosing the often-devastating movement disorder, particularly in its early stages, ...

The Sanofi equity investment means the Big Pharma will receive exclusive rights of first negotiation surrounding VTX3232, an ...

The FBC Fitness Rock Steady Boxing program has been shown to benefit people with Parkinson's disease, the fitness center's director told last week's weekly meeting of Hot Springs National Park Rotary ...

MSIG Insurance, a provider of general insurance solutions in Asia and part of the MS&AD Insurance Group, has introduced ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...